PainReform Ltd. Files 6-K, Incorporates Press Release
Ticker: PRFX · Form: 6-K · Filed: Apr 16, 2024 · CIK: 1801834
| Field | Detail |
|---|---|
| Company | Painreform Ltd. (PRFX) |
| Form Type | 6-K |
| Filed Date | Apr 16, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Key Dollar Amounts | $4 Million |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, registration-statement
TL;DR
PainReform filed a 6-K, nothing new but it's now part of their S-8 and F-3 filings.
AI Summary
PainReform Ltd. filed a Form 6-K on April 16, 2024, to report information for the month of April 2024. This filing incorporates by reference the company's press release into its existing Registration Statements on Form S-8 and Form F-3.
Why It Matters
This filing serves as an update and incorporates previous disclosures into ongoing registration statements, which is standard procedure for companies with publicly traded securities.
Risk Assessment
Risk Level: low — The filing is a routine administrative report and does not contain new material financial or operational information.
Key Players & Entities
- PainReform Ltd. (company) — Filer of the Form 6-K
- April 16, 2024 (date) — Filing date of the Form 6-K
- Form S-8 (document) — Registration statement into which the 6-K is incorporated
- Form F-3 (document) — Registration statement into which the 6-K is incorporated
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is filed by PainReform Ltd. to report information for the month of April 2024 and incorporates by reference a press release into the company's existing Registration Statements on Form S-8 and Form F-3.
When was this Form 6-K filed?
This Form 6-K was filed on April 16, 2024.
Which registration statements does this filing update?
This filing is incorporated by reference into PainReform Ltd.'s Registration Statements on Form S-8 (Registration No. 333-257968 and 333-265902) and Form F-3 (Registration No. 333-259318, 333-254982 and 333-276485).
Is this filing a report of a foreign private issuer?
Yes, the Form 6-K is titled 'Report of Foreign Private Issuer'.
What is the principal executive office address of PainReform Ltd.?
The principal executive offices are located at 65 Yigal Alon St., Tel Aviv 6744316, Israel.
Filing Stats: 255 words · 1 min read · ~1 pages · Grade level 9.6 · Accepted 2024-04-16 08:17:02
Key Financial Figures
- $4 Million — titled "PainReform Announces Pricing of $4 Million Public Offering." A copy of the press r
Filing Documents
- zk2431290.htm (6-K) — 10KB
- exhibit_99-1.htm (EX-99.1) — 11KB
- 0001178913-24-001322.txt ( ) — 22KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: April 16, 2024 PAINREFORM LTD. By: /s/ Ilan Hadar Ilan Hadar Chief Executive Officer 3